Bioconjugates of rhizavidin with single domain antibodies as bifunctional immunoreagents

Journal of Immunological Methods

Volumn 411, Issue , 2014, Pages 37-42

  Liu, Jinny L ^a   Zabetakis, Dan ^a   Walper, Scott A ^a   Goldman, Ellen R ^a   Anderson, George P ^a  

^a NAVAL RESEARCH LABORATORY   (United States)

Author keywords

MAGPIX; Rhizavidin; Ricin; Single domain antibodies; Streptavidin; Surface plasmon resonance

Indexed keywords

ANTIBODY CONJUGATE; REAGENT; SINGLE DOMAIN ANTIBODY RHIZAVIDIN BIOCONJUGATE; STREPTAVIDIN; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; BIOTIN; HYBRID PROTEIN; NANOBODY; RHIZAVIDIN, RHIZOBIUM ETLI; RICIN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; IMMUNOASSAY; NONHUMAN; THERMOSTABILITY; ANIMAL; CHEMISTRY; GENETICS; IMMUNOLOGY; MAGPIX; MOUSE; RHIZAVIDIN; SURFACE PLASMON RESONANCE;

MAGPIX; RHIZAVIDIN; RICIN; SINGLE DOMAIN ANTIBODIES; STREPTAVIDIN; SURFACE PLASMON RESONANCE;

ANIMALS; BACTERIAL PROTEINS; BIOTIN; IMMUNOCONJUGATES; MICE; RECOMBINANT FUSION PROTEINS; SINGLE-CHAIN ANTIBODIES; STREPTAVIDIN;

EID: 84907063234     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2014.06.004     Document Type: Article

References (30)

1. Anderson G.P., Liu J.L., Hale M.L., Bernstein R.D., Moore M., Swain M.D., Goldman E.R. Development of antiricin single domain antibodies toward detection and therapeutic reagents. Anal. Chem. 2008, 80:9604.
2. Anderson G.P., Kowtha V.A., Taitt C.R. Detection of fumonisin B1 and ochratoxin A in grain products using microsphere-based fluid array immunoassays. Toxins 2010, 2:297.
3. Avrameas S. Amplification systems in immunoenzymatic techniques. J. Immunol. Methods 1992, 150:23.
4. Bird R.E., Hardman K.D., Jacobson J.W., Johnson S., Kaufman B.M., Lee S.M., Lee T., Pope S.H., Riordan G.S., Whitlow M. Single-chain antigen-binding proteins. Science 1988, 242:423.
5. Chapman-Smith A., Cronan J.E. The enzymatic biotinylation of proteins: a post-translational modification of exceptional specificity. Trends Biochem. Sci. 1999, 24:359.
6. Chen X., Zaro J.L., Shen W.C. Fusion protein linkers: property, design and functionality. Adv. Drug Deliv. Rev. 2013, 65:1357.
7. Cloutier S.M., Couty S., Terskikh A., Marguerat L., Crivelli V., Pugni'res M., Mani J.C., Leisinger H.J., Mach J.P., Deperthes D. Streptabody, a high avidity molecule made by tetramerization of in vivo biotinylated, phage display-selected scFv fragments on streptavidin. Mol. Immunol. 2000, 37:1067.
8. Cronan J.E. Biotination of proteins in vivo. a post-translational modification to label, purify, and study proteins. J. Biol. Chem. 1990, 265:10327.
9. de Marco A. Biotechnological applications of recombinant single-domain antibody fragments. Microb. Cell Factories 2011, 10:44.
10. Diamandis E.P., Christopoulos T.K. The biotin (strept)avidin system-principles and applications in biotechnology. Clin. Chem. 1991, 37:625.
11. Dubel S., Breitling F., Kontermann R., Schmidt T., Skerra A., Little M. Bifunctional and multimeric complexes of streptavidin fused to single-chain antibodies (Scfv). J. Immunol. Methods 1995, 178:201.
12. Eyer L., Hruska K. Single-domain antibody fragments derived from heavy-chain antibodies: a review. Vet. Med. 2012, 57:439.
13. Ghahroudi M.A., Desmyter A., Wyns L., Hamers R., Muyldermans S. Selection and identification of single domain antibody fragments from camel heavy-chain antibodies. FEBS Lett. 1997, 414:521.
14. Hage D.S. Immunoassays. Anal. Chem. 1993, 65:R420.
15. Helppolainen S.H., Nurminen K.P., Maatta J.A., Halling K.K., Slotte J.P., Huhtala T., Liimatainen T., Yla-Herttuala S., Airenne K.J., Narvanen A., Janis J., Vainiotalo P., Valjakka J., Kulomaa M.S., Nordlund H.R. Rhizavidin from Rhizobium etli: the first natural dimer in the avidin protein family. Biochem. J. 2007, 405:397.
16. Hermanson G.T. Avidin-biotin systems, in bioconjugate techniques 2008, 900. Academic Press, Amsterdam. second ed.
17. Holliger P., Hudson P.J. Engineered antibody fragments and the rise of single domains. Nat. Biotechnol. 2005, 23:1126.
18. Huston J.S., Levinson D., Mudgett-Hunter M., Tai M.S., Novotny J., Margolies M.N., Ridge R.J., Bruccoleri R.E., Haber E., Crea R., et al. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:5879.
19. Kipriyanov S.M., Little M., Kropshofer H., Breitling F., Gotter S., Dubel S. Affinity enhancement of a recombinant antibody: formation of complexes with multiple valency by a single-chain Fv fragment-core streptavidin fusion. Protein Eng. 1996, 9:203.
20. Lin Y.K., Pagel L.M., Axworthy D., Pantelias A., Hedin N., Press O.W. A genetically engineered anti-CD45 single-chain antibody-streptavidin fusion protein for pretargeted radioimmunotherapy of hematologic malignancies. Cancer Res. 2006, 66:3884.
21. Liu J.L., Zabetakis D., Acevedo-Velez G., Goldman E.R., Anderson G.P. Comparison of an antibody and its recombinant derivative for the detection of the small molecule explosive 2,4,6-trinitrotoluene. Anal. Chim. Acta. 2013, 759:100.
22. Liu J.L., Zabetakis D., Goldman E.R., Anderson G.P. Selection and evaluation of single domain antibodies toward MS2 phage and coat protein. Mol. Immunol. 2013, 53:118.
23. Meir A., Helppolainen S.H., Podoly E., Nordlund H.R., Hytonen V.P., Maatta J.A., Wilchek M., Bayer E.A., Kulomaa M.S., Livnah O. Crystal structure of rhizavidin: insights into the enigmatic high-affinity interaction of an innate biotin-binding protein dimer. J. Mol. Biol. 2009, 386:379.
24. Pagel J.M., Hedin N., Drouet L., Pantelias A., Lin Y., Hamlin D., Fisher D., Wilbur D.S., Gopal A.K., Green D., Appelbaum F.R., Press O.W. Conventional and pretargeted radioimmunotherapy using an anti-murine CD45 monoclonal antibody in a syngeneic, disseminated murine leukemia model. Blood 2006, 108. (172a-172a).
25. Sano T., Pandori M.W., Chen X., Smith C.L., Cantor C.R. Recombinant core streptavidins. A minimum-sized core streptavidin has enhanced structural stability and higher accessibility to biotinylated macromolecules. J. Biol. Chem. 1995, 270:28204.
26. Schultz J., Lin Y., Sanderson J., Zuo Y., Stone D., Mallett R., Wilbert S., Axworthy D. A tetravalent single-chain antibody-streptavidin fusion protein for pretargeted lymphoma therapy. Cancer Res. 2000, 60:6663.
27. Turner K.B., Zabetakis D., Goldman E.R., Anderson G.P. Enhanced stabilization of a stable single domain antibody for SEB toxin by random mutagenesis and stringent selection. Protein Eng. Des. Sel. 2014, 27:89.
28. Walper S.A., Anderson G.P., Brozozog Lee P.A., Glaven R.H., Liu J.L., Bernstein R.D., Zabetakis D., Johnson L., Czarnecki J.M., Goldman E.R. Rugged single domain antibody detection elements for Bacillus anthracis spores and vegetative cells. PLoS One 2012, 7:e32801.
29. Walper S.A., Brozozog Lee P.A., Goldman E.R., Anderson G.P. Comparison of single domain antibody immobilization strategies evaluated by surface plasmon resonance. J. Immunol. Methods 2013, 388:68.
30. Wang W.W.S., Das D., McQuarrie S.A., Suresh M.R. Design of a bifunctional fusion protein for ovarian cancer drug delivery: single-chain anti-CA125 core-streptavidin fusion protein. Eur. J. Pharm. Biopharm. 2007, 65:398.